Tag Archives: Mara Goldstein

Mizuho Securities Keeps a Buy Rating on Forty Seven (FTSV)

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Forty Seven (FTSV – Research Report) today and set a price target of $18.00. The company’s shares closed last Monday at $9.44. According to TipRanks.com, Goldstein is ranked 0 out

Arcus Biosciences (RCUS) Gets a Buy Rating from Mizuho Securities

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) yesterday and set a price target of $22.00. The company’s shares closed last Monday at $7.54, close to its 52-week low of $6.30. According

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Xencor (NASDAQ: XNCR), Xoma (NASDAQ: XOMA) and Urovant Sciences (NASDAQ: UROV)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xencor (XNCR – Research Report), Xoma (XOMA – Research Report) and Urovant Sciences (UROV – Research Report). Xencor (XNCR) In a report released yesterday, Mara

Mizuho Securities Keeps a Buy Rating on Corvus Pharmaceuticals Inc (CRVS)

In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Buy rating on Corvus Pharmaceuticals Inc (CRVS – Research Report), with a price target of $7.00. The company’s shares closed last Monday at $3.66. According to TipRanks.com, Goldstein

Incyte Corp (INCY) Gets a Buy Rating from Mizuho Securities

In a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Incyte Corp (INCY – Research Report), with a price target of $95.00. The company’s shares closed last Monday at $79.86. According to TipRanks.com, Goldstein is

Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences Inc (RCUS), Urogen Pharma Ltd (URGN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcus Biosciences Inc (RCUS – Research Report) and Urogen Pharma Ltd (URGN – Research Report) with bullish sentiments. Arcus Biosciences Inc (RCUS)